SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
Irene Cassaniti, Elena Percivalle, Federica Bergami, Antonio Piralla, Giuditta Comolli, Raffaele Bruno, Marco Vecchia, Margherita Sambo, Marta Colaneri, Valentina Zuccaro, Marco Benazzo, Carlo Robotti, Anna Calastri, Eugenia Maiorano, Alessandro Ferrari, Giuseppe Cambiè, Fausto Baldanti
Topics & Concepts
ELISPOTEx vivoVirologyImmunityCoronavirus disease 2019 (COVID-19)ImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakCellular immunityBiologyIn vivoT cellImmune systemInfectious disease (medical specialty)PathologyDiseaseOutbreakBiotechnologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19